Your naive, the stock would still be down 85% whether results came out or not. The sharks circling know its about approval and or revenue.
Dr. Missling is making sure the results are prepared the way the Fda likes to receive them (Kun Jin said as much recently) and supported by a 3rd party peer reviewed paper.
No need to reply, I understand your number one priority of concern is about your capital preservation. Its all about buying in at the right price (bottom) and the stock only goes up from there. Maybe BIIB would he a good fit, they are past due for a 20 billion dollar PR bump. You might also try SAVA or Annovis, both are beaten down pretty good and might be nearing entry with the above mentioned priority.